|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61P 1/16 | (2018.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 38/1796 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/6811 | (2017.08) | ||
| A61K 47/68 | (2017.08) |
| (11) | Number of the document | 3936142 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20832900.3 |
| Date of filing the European patent application | 2020-06-29 | |
| (97) | Date of publication of the European application | 2022-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2020/008479 |
| Date | 2020-06-29 |
| (87) | Number | WO 2020/263063 |
| Date | 2020-12-30 |
| (30) | Number | Date | Country code |
| 20190077776 | 2019-06-28 | KR | |
| 20200004386 | 2020-01-13 | KR | |
| 20200004379 | 2020-01-13 | KR | |
| 20200069219 | 2020-06-08 | KR |
| (72) |
KWON, Hyun Joo , KR
KIM, Jung Kuk , KR
PARK, Eun Jin , KR
LEE, Jong Min , KR
LEE, Jong Suk , KR
JO, Hyo Sang , KR
CHOI, In Young , KR
|
| (73) |
Hanmi Pharm. Co., Ltd. ,
214 Muha-ro
Paltan-myeon, Hwaseong-si, Gyeonggi-do 18536,
KR
|
| (54) | TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS FOR TREATING LIVER DISEASE |
| TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS FOR TREATING LIVER DISEASE |